Status:
UNKNOWN
Investigating the Use of a Brain-computer Interface Based on TMS Neurofeedback for Upper Limb Stroke Rehabilitation
Lead Sponsor:
University of Dublin, Trinity College
Collaborating Sponsors:
St. James Hospital
Conditions:
Transcranial Magnetic Stimulation
Stroke
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The mechanisms and effectiveness of a technique to boost the brain's recovery mechanisms will be studied. Brain-Computer Interface (BCI),based on applying magnetic pulses (Transcranial Magnetic Stimul...
Detailed Description
Participants will undergo transcranial magnetic stimulation (TMS) neurofeedback (NF) incorporated into a computer game that is tailored to train the individuals to produce larger than baseline motor e...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Be in the sub-acute phase (2-26 weeks) post stroke.
- Single hemisphere lesion
- No previous transient ischemic attack (TIA)
- Upper limb functional impairment (0-2 power)
- No or negligible OCS broken hearts test score (visual neglect)
- No or almost no cognitive impairment (Pass or near pass MMSE and MOCA)
- Passes TMS-Safety Questionnaire
- Detectable motor evoked potential (MEP) in response to TMS
- The exclusion criteria include:
- History of neuromuscular, neurological or active psychiatric disease (as these conditions and their respective medications may influence corticomotor excitability).
- History of epilepsy or risk of reduced seizure threshold. There is a small remote risk of seizure associated with high-frequency repetitive TMS, which is NOT used in the current protocol. This study uses classical protocols and parameters that fall within the safety limits reported by Rossi et al (2009). Therefore this exclusion criteria is purely an additional precaution.
- Presence of metallic implants in the head. The sole absolute contraindication to TMS is the presence of metallic implants near to the discharging coils. Exclusion is to avoid risk of heating, malfunction in the implanted device, or cause seizure.
- History of anxiety-induced fainting. Patients with a history of anxiety induced fainting are at a small risk of fainting due to taking part in the study or hearing the 'clicking' sound produced by the TMS coil discharging.
- History of reaction or allergy to equipment or the skin preparation gel used to clean the skin surface prior to placing EMG electrodes. While allergic reaction to any of the materials used us very unlikely, any participants with history of adverse reaction to the environments or materials used (or similar) will be excluded to protect their wellbeing and prevent distress.
- Use of illicit drugs or other neurotransmission-altering drugs. These influence the brain and hence may impact upon the TMS or MRI measurements.
- Consumption of alcohol on the night preceding the recordings- to avoid potential influence of residual alcohol on neural network activity.
- Insufficient sleep on the night preceding the recording to prevent participants falling asleep or dozing during the recording, which would influence task performance. This is also in keeping with the guidelines of Rossi et al (2009).
- Eating very little in the 6 hours preceding the study- to avoid weakness or faintness.
- Any medical condition associated with neuropathy (eg.diabetes), seizure disorder, brain tumours, structural brain diseases, other degenerative brain diseases and other comorbidities (e.g human immunodeficiency virus). This is to prevent abnormal neural activity generating data related to something other than that of the diagnosis under study (stroke).
- Any head trauma injury associated with loss of consciousness.
- Regular, severe headaches
- Noise induced hearing loss, or ringing in the ears.
- Possible pregnancy
- Implanted Neurostimulator
- Anxiety in Hospital settings
Exclusion
Key Trial Info
Start Date :
June 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06164912
Start Date
June 1 2023
End Date
August 1 2025
Last Update
December 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St James' Hospital
Dublin, Leinster, Ireland, D08 NHY1